Author:
Grunwald Iris Q.,Fassbender Klaus,Wakhloo Ajay K.
Publisher
Springer Berlin Heidelberg
Reference31 articles.
1. Bernard CDC, Iburg KM, Inoue M, Ma Fat D, Shibuya K, Stein C, Tomijima T, Xu H (2003) Global burden of disease in 2002: data sources, methods and results.
http://www.who.int/infobase
. Accessed 20 Apr 2011
2. Bogousslavsky J, Paciaroni M (2009) The economics of treating stroke as an acute brain attack. BMC Med 7:51
3. Branston NM, Hope DT, Symon L (1979) Barbiturates in focal ischemia of primate cortex: effects on blood flow distribution, evoked potential and extracellular potassium. Stroke 10:647–653
4. Cadilhac D, Dewey H et al. (2005) Investing in stroke – what are the potential cost offsets from the strokesafe program. National Stroke Research Institute – Technical Report (unpublished)
5. Caro JJ, Huybrechts KF (1999) Stroke treatment economic model (STEM): predicting long term costs from functional status. Stroke 30:2574–2579